O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer
Titel:
O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer
Auteur:
André, T. Shiu, K. Kim, T. Jensen, B. Jensen, L. Punt, C. Smith, D. Garcia-Carbonero, R. Alcaide García, J. Gibbs, P. De la Fouchardière, C. Rivera Herrero, F. Elez, E. Bendell, J. Le, D. Yoshino, T. Zhong, W. Fogelman, D. Marinello, P. Diaz Jr., L.